Atlas Trials

Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment

Clinical trial NCT05334290 · UNKNOWN

Trial details

NCT number
NCT05334290
Sponsor
Massimo Falconi
Status
UNKNOWN
Study type
OBSERVATIONAL
Neuroendocrine Tumors
Start date
2020-08-06
Primary completion
2023-10-05
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.